BIOX on Nasdaq
Bioceres Crop Solutions Corp.
In its 2025 annual report (Form 20-F) the company says: “We are a leading company in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. We have a unique biotech platform with high-impact, licensed and patented technologies for seeds and microbial ag-inputs, as well as biological and next generation conventional crop nutrition and protection solutions.”5 It is headquartered in Rosario, Argentina.2 Its shares trade on Nasdaq under the symbol BIOX.2
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with AMERICAN VANGUARD CORP, CVR PARTNERS, LP or The Scotts Miracle-Gro Company, or pick any stock.
- TickerBIOX on Nasdaq2
- IndustryAgricultural Chemicals2
- HeadquartersRosario, Argentina2
- Incorporated inCayman Islands4
- Business addressPo Box 309, Ugland House, George Town, Grand Cayman, E9 Ky1-11044
- Filer categoryAccelerated filer4
- Legal formcompany limited by shares2
- LEI549300SBSSIZUVSY4U272
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressP.O. Box 309, Ugland House, KY1-1104 George Town, Cayman Islands2
- Registered withGeneral Registry, MC-3292142
See how the biggest companies compare on our leaderboards
We are a leading company in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. We have a unique biotech platform with high-impact, licensed and patented technologies for seeds and microbial ag-inputs, as well as biological and next generation conventional crop nutrition and protection solutions.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Crop protection brought in 54% of the revenue Bioceres Crop Solutions Corp. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Crop protection | $205.8M | $223.5M | $181.9M |
| Crop nutrition | $157.3M | $144.8M | $89.5M |
| Seed and integrated products | $56.9M | $96.4M | $63.7M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue55¢$203.4M
- Research and development4¢$14.9M
- Selling, general and admin33¢$123.1M
- Interest8¢$28.8M
- Income tax0¢$1.3M
Out of $335.1M in revenue.3 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending11¢$5.6M
- Dividends paid0¢$72.1K
- Share buybacks2¢$926.9K
- Kept or used elsewhere87¢$43.3M
Out of $49.9M of cash from operations.3
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|
| Revenues from contracts with customers | $333.3M | $464.8M | $419.4M |
| Initial recognition and changes in the fair value of biological assets at the point of harvest | $1.8M | -$45.7K | $610.6K |
| Cost of sales | -$203.4M | -$278.2M | -$235.5M |
| Changes in the net realizable value of agricultural products after harvest | -$1.5M | -$2.4M | -$4.4M |
| Research and development expenses | -$14.9M | -$17.2M | -$15.3M |
| Selling, general and administrative expenses | -$123.1M | -$123.7M | -$113.0M |
| Share of profit or loss of joint ventures and associates | -$1.1M | $4.0M | $1.2M |
| Other income or expenses, net | $6.8M | -$1.5M | $1.1M |
| Operating (loss)/ profit | -$2.2M | $45.9M | $54.2M |
| Financial cost | -$28.8M | -$26.9M | -$23.8M |
| Other financial results | -$26.5M | -$7.9M | -$11.3M |
| (Loss)/ Profit before income tax | -$57.6M | $11.1M | $19.1M |
| Income tax | -$1.3M | -$3.8M | $1.1M |
| (Loss)/ Profit for the year | -$58.8M | $7.3M | $20.2M |
| Equity holders of the parent | -$55.4M | $4.3M | $18.8M |
| Non-controlling interests | -$3.4M | $3.0M | $1.4M |
| Basic loss attributable to ordinary equity holders of the parent | -$0.88 | $0.07 | $0.30 |
| Diluted loss attributable to ordinary equity holders of the parent | -$0.88 | $0.07 | $0.30 |
| Other comprehensive (loss) | -$714.3K | -$787.4K | -$835.8K |
| Items that may be subsequently reclassified to (loss)/ profit | -$714.3K | -$787.4K | $631.5K |
| Foreign exchange differences on translation of foreign operations from joint ventures | -$238 | -$46.9K | |
| Foreign exchange differences on translation of foreign operations | -$714.3K | -$787.1K | $678.4K |
| Items that will not be subsequently reclassified to loss and profit | -$1.5M | ||
| Revaluation of property, plant and equipment, net of tax, of joint ventures and associates 1 | -$184.6K | ||
| Revaluation of property, plant and equipment, net of tax 2 | -$1.3M | ||
| Equity holders of the parent | -$56.0M | $3.8M | $17.9M |
| Non-controlling interests | -$3.6M | $2.7M | $1.4M |
| Total comprehensive (loss)/ profit | -$59.6M | $6.5M | $19.3M |
| Tax effect of the revaluation of property, plant and equipment of joint venture and associates | $99.4K | ||
| Tax effect of the revaluation of property, plant and equipment | $703.1K |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $32.7M | $44.5M | ||
| Other financial assets | $2.0M | $11.7M | ||
| Trade receivables | $165.9M | $207.3M | ||
| Other receivables | $15.9M | $18.3M | ||
| Recoverable income tax | $1.9M | $655.7K | ||
| Inventories | $87.6M | $125.9M | ||
| Biological assets | $2.4M | $294.1K | $146.8K | |
| Total current assets | $308.3M | $408.7M | ||
| Other financial assets | $58 | $634.6K | ||
| Trade receivables | $2.5M | |||
| Other receivables | $23.7M | $18.0M | ||
| Recoverable income tax | $18.0K | $10.9K | ||
| Deferred tax assets | $4.9M | $9.7M | ||
| Investments in joint ventures and associates | $39.4M | $39.8M | ||
| Investment properties | $570.3K | $560.8K | ||
| Property, plant and equipment | $74.6M | $74.6M | $67.9M | |
| Intangible assets | $181.2M | $176.9M | $173.8M | |
| Goodwill | $112.2M | $112.2M | ||
| Right of use asset | $16.4M | $11.6M | ||
| Total non-current assets | $455.3M | $443.9M | ||
| Total assets | $763.6M | $852.5M | ||
| Trade and other payables | $96.4M | $168.7M | ||
| Borrowings | $119.7M | $136.7M | ||
| Employee benefits and social security | $6.2M | $7.3M | ||
| Deferred revenue and advances from customers | $4.3M | $3.9M | ||
| Income tax payable | $452.8K | $4.8M | ||
| Consideration for acquisition | $1.8M | $4.6M | ||
| Secured notes | $102.3M | |||
| Lease liabilities | $6.9M | $3.1M | ||
| Total current liabilities | $338.0M | $329.3M | ||
| Trade and other payables | $48.5M | |||
| Borrowings | $38.2M | $42.1M | ||
| Deferred revenue and advances from customers | $1.4M | $1.9M | ||
| Joint ventures and associates | $1.0M | $296.5K | ||
| Deferred tax liabilities | $30.1M | $35.0M | ||
| Provisions | $1.3M | $1.3M | ||
| Consideration for acquisition | $397.8K | $2.3M | ||
| Secured notes | $80.8M | |||
| Lease liabilities | $9.5M | $8.2M | ||
| Total non-current liabilities | $130.4M | $171.9M | ||
| Total liabilities | $468.4M | $501.2M | ||
| Equity attributable to owners of the parent | $265.4M | $315.0M | ||
| Non-controlling interest | $29.8M | $36.3M | ||
| Total equity | $295.2M | $351.4M | $330.5M | $158.3M |
| Total equity and liabilities | $763.6M | $852.5M |
| Period ending | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $32.7M | $44.5M | ||
| Other financial assets | $2.0M | $11.7M | ||
| Trade receivables | $165.9M | $207.3M | ||
| Other receivables | $15.9M | $18.3M | ||
| Recoverable income tax | $1.9M | $655.7K | ||
| Inventories | $87.6M | $125.9M | ||
| Biological assets | $2.4M | $294.1K | $146.8K | |
| Total current assets | $308.3M | $408.7M | ||
| Other financial assets | $58 | $634.6K | ||
| Trade receivables | $2.5M | |||
| Other receivables | $23.7M | $18.0M | ||
| Recoverable income tax | $18.0K | $10.9K | ||
| Deferred tax assets | $4.9M | $9.7M | ||
| Investments in joint ventures and associates | $39.4M | $39.8M | ||
| Investment properties | $570.3K | $560.8K | ||
| Property, plant and equipment | $74.6M | $74.6M | $67.9M | |
| Intangible assets | $181.2M | $176.9M | $173.8M | |
| Goodwill | $112.2M | $112.2M | ||
| Right of use asset | $16.4M | $11.6M | ||
| Total non-current assets | $455.3M | $443.9M | ||
| Total assets | $763.6M | $852.5M | ||
| Trade and other payables | $96.4M | $168.7M | ||
| Borrowings | $119.7M | $136.7M | ||
| Employee benefits and social security | $6.2M | $7.3M | ||
| Deferred revenue and advances from customers | $4.3M | $3.9M | ||
| Income tax payable | $452.8K | $4.8M | ||
| Consideration for acquisition | $1.8M | $4.6M | ||
| Secured notes | $102.3M | |||
| Lease liabilities | $6.9M | $3.1M | ||
| Total current liabilities | $338.0M | $329.3M | ||
| Trade and other payables | $48.5M | |||
| Borrowings | $38.2M | $42.1M | ||
| Deferred revenue and advances from customers | $1.4M | $1.9M | ||
| Joint ventures and associates | $1.0M | $296.5K | ||
| Deferred tax liabilities | $30.1M | $35.0M | ||
| Provisions | $1.3M | $1.3M | ||
| Consideration for acquisition | $397.8K | $2.3M | ||
| Secured notes | $80.8M | |||
| Lease liabilities | $9.5M | $8.2M | ||
| Total non-current liabilities | $130.4M | $171.9M | ||
| Total liabilities | $468.4M | $501.2M | ||
| Equity attributable to owners of the parent | $265.4M | $315.0M | ||
| Non-controlling interest | $29.8M | $36.3M | ||
| Total equity | $295.2M | $351.4M | $330.5M | $158.3M |
| Total equity and liabilities | $763.6M | $852.5M |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|
| (Loss)/ Profit for the year | -$58.8M | $7.3M | $20.2M |
| Income tax | $1.3M | $3.8M | -$1.1M |
| Financial results | $55.3M | $34.8M | $35.1M |
| Depreciation of property, plant and equipment | $6.0M | $5.8M | $4.8M |
| Amortization of intangible assets | $11.2M | $12.1M | $11.0M |
| Depreciation of leased assets | $5.0M | $3.4M | $3.6M |
| Transactional expenses | $4.0M | $1.1M | $4.2M |
| Share-based incentive and stock options | $4.4M | $14.1M | $3.4M |
| Share of profit or loss of joint ventures and associates | $1.1M | -$4.0M | -$1.2M |
| Loss of participation in joint ventures and associates | $133.1K | ||
| Gain from a bargain purchase | -$1.0M | ||
| Provisions for contingencies | $335.8K | $367.1K | $221.0K |
| Allowance for impairment of trade debtors | $7.1M | $753.4K | $1.3M |
| Allowance for obsolescence | $1.5M | $586.5K | $1.1M |
| Initial recognition and changes in the fair value of biological assets | -$1.8M | $45.7K | -$610.6K |
| Changes in the net realizable value of agricultural products after harvest | $1.5M | $2.4M | $4.4M |
| Gain on sale of equipment and intangible assets | -$7.8M | -$125.5K | -$74.6K |
| Trade receivables | $25.5M | -$46.7M | -$56.9M |
| Other receivables | -$916.4K | -$5.0M | -$11.5M |
| Income and minimum presumed income taxes | -$7.0M | $4.8M | -$16.2M |
| Inventories and biological assets | $34.9M | $14.2M | -$11.1M |
| Trade and other payables | -$32.0M | $14.2M | -$4.5M |
| Employee benefits and social security | -$1.2M | -$2.3M | $1.3M |
| Deferred revenue and advances from customers | -$128.7K | -$21.1M | $13.3M |
| Income taxes paid | -$853.3K | -$4.1M | |
| Interest collected | $120.6K | $2.7M | $5.4M |
| Inflation effects on working capital adjustments | $139.9K | $321.1K | $376.6K |
| Net cash flows generated by operating activities | $49.9M | $41.7M | $2.6M |
| Proceeds from sale of property, plant and equipment | $390.4K | $336.7K | $137.4K |
| Net cash received from business combination | $37.5K | $4.4M | |
| Proceeds from financial assets | $19.3M | $888.1K | $1.3M |
| Investment in financial assets | -$11.2M | -$7.2M | -$9.0M |
| Purchase of property, plant and equipment | -$5.6M | -$9.8M | -$11.4M |
| Capitalized development expenditures | -$8.6M | -$11.9M | -$10.8M |
| Purchase of intangible assets | -$350.8K | -$1.1M | -$449.7K |
| Net cash flows used by investing activities | -$6.1M | -$28.7M | -$25.7M |
| Proceeds from borrowings | $266.4M | $135.8M | $79.8M |
| Repayment of borrowings and financed payments | -$288.5M | -$112.6M | -$16.7M |
| Interest payments | -$18.9M | -$24.7M | -$18.0M |
| Other financial payments | -$3.2M | -$2.7M | -$4.8M |
| Purchase of own shares | -$926.9K | -$734.4K | -$3.0M |
| Leased assets payments | -$5.5M | -$4.9M | -$3.9M |
| Cash dividend distributed by subsidiary | -$72.1K | -$174.8K | -$452.1K |
| Net cash flows (used by)/ generated by financing activities | -$50.7M | -$10.1M | $33.0M |
| Net (decrease)/ increase in cash and cash equivalents | -$6.9M | $2.9M | $9.8M |
| Inflation effects on cash and cash equivalents | $2.6K | -$31.9K | -$101.8K |
| Effect of exchange rate changes on cash and equivalents | -$4.9M | -$6.6M | $4.9M |
No quarter-by-quarter statement was filed.
Corporate structure
Bioceres Crop Solutions Corp. is part of a group headed by BIOCERES LLC. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Bioceres Crop Solutions Corp.
- Agriculture Investment Group Corp. Filed SCHEDULE 13D/A on Bioceres Crop Solutions Corp., latest Jul 7, 2026 (9 filings since Oct 29, 2025)
- DRACO Capital Investment Management Co Ltd Filed SCHEDULE 13G/A on Bioceres Crop Solutions Corp., latest Feb 12, 2026 (5 filings since Aug 4, 2022)
- Fourth Sail Capital LP Filed SCHEDULE 13G/A on Bioceres Crop Solutions Corp., latest Jan 21, 2026 (5 filings since Oct 23, 2024)
- Jasper Lake Ventures One LLC Filed SCHEDULE 13D/A on Bioceres Crop Solutions Corp., latest Jan 21, 2026 (4 filings since Aug 8, 2025)
- BAF Latam Credit Fund B.V. Filed SCHEDULE 13G/A on Bioceres Crop Solutions Corp., latest Nov 12, 2025 (2 filings since Aug 13, 2025)
- Bioceres Group Ltd Filed SCHEDULE 13D/A on Bioceres Crop Solutions Corp., latest Oct 28, 2025 (9 filings since Mar 25, 2024)
- Solel Partners LP Filed SC 13G/A on Bioceres Crop Solutions Corp., latest Feb 14, 2024 (2 filings since Feb 14, 2023)
- ARDSLEY ADVISORY PARTNERS LP Filed SC 13G on Bioceres Crop Solutions Corp., latest Jan 25, 2023
- Bioceres S.A. Filed SC 13D/A on Bioceres Crop Solutions Corp., latest Nov 17, 2022 (4 filings since Oct 15, 2021)
- Ospraie Ag Science LLC Filed SC 13G on Bioceres Crop Solutions Corp., latest Jul 15, 2022
- 5DPlus Capital Investment Management Co S.A. Filed SC 13G/A on Bioceres Crop Solutions Corp., latest Feb 14, 2022 (2 filings since Oct 4, 2021)
- BIOCERES LLC Wilmington, Delaware, United States
- Bioceres Crop Solutions Corp. Rosario, Argentina
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Bioceres Crop Solutions Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, net | $74.6M3 Jun 30, 2025 | $74.6M3 Jun 30, 2024 | 0% |
| Operating-lease assets (leased space) | $16.4M3 Jun 30, 2025 | $11.6M3 Jun 30, 2024 | +41.2% |
Real estate and locations
| Item | Latest | A year before | Change |
|---|---|---|---|
| Real estate investments, net | $570.3K3 Jun 30, 2025 | $560.8K3 Jun 30, 2024 | +1.7% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $32.7M3 Jun 30, 2025 | $44.5M3 Jun 30, 2024 | −26.5% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $112.2M3 Jun 30, 2025 | $112.2M3 Jun 30, 2024 | 0% |
| Intangible assets, net (excluding goodwill) | $181.2M3 Jun 30, 2025 | $176.9M3 Jun 30, 2024 | +2.4% |
Inventory
Leadership
Who has led Bioceres Crop Solutions Corp., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerFederico Trucco May 11, 2026 to now11
- Chief financial officerEzequiel Simmermacher Apr 20, 2026 to now12
Board members and other officers (4)
- Board memberFederico Trucco May 11, 2026 to now11
- Board memberYogesh Mago May 11, 2026 to now13
- Board memberNarain Duraiswami May 12, 2026 to now14
- General counselJose Augusto Roque Apr 22, 2026 to now15
Subsidiaries and ownership
Parent company (GLEIF)
Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.
Timeline
Calendar
Coming up
- Nov 11, 2026Reports results for the quarter ending Sep/202616
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
182 filings to the SEC since October 2021: 5 annual reports, 9 insider forms, 44 large holders, 124 other. The latest 20:
- Sep 21, 20266-K EDGAR
- Sep 16, 20266-K EDGAR
- Aug 10, 20264/A OWNERSHIP DOCUMENT EDGAR
- Aug 6, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 4, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 7, 2026SCHEDULE 13D/A EDGAR
- Jun 22, 20266-K EDGAR
- Jun 1, 2026SCHEDULE 13D/A EDGAR
- Jun 1, 20266-K EDGAR
- May 12, 20263 OWNERSHIP DOCUMENT EDGAR
- May 12, 20266-K EDGAR
- May 11, 20263/A OWNERSHIP DOCUMENT EDGAR
- May 11, 20263 OWNERSHIP DOCUMENT EDGAR
- May 11, 20263 OWNERSHIP DOCUMENT EDGAR
- Apr 28, 2026SCHEDULE 13D/A EDGAR
- Apr 22, 20263 OWNERSHIP DOCUMENT EDGAR
- Apr 20, 20263 OWNERSHIP DOCUMENT EDGAR
- Mar 24, 2026SCHEDULE 13D/A EDGAR
- Mar 17, 20266-K EDGAR
- Mar 17, 20266-K EDGAR
The 182 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Agriculture Investment Group Corp.SCHEDULE 13D/A, 9 filings Oct 29, 2025 to Jul 7, 202617
- DRACO Capital Investment Management Co LtdSCHEDULE 13G/A, 5 filings Aug 4, 2022 to Feb 12, 202618
- Fourth Sail Capital LPSCHEDULE 13G/A, 5 filings Oct 23, 2024 to Jan 21, 202619
- Jasper Lake Ventures One LLCSCHEDULE 13D/A, 4 filings Aug 8, 2025 to Jan 21, 202620
- BAF Latam Credit Fund B.V.SCHEDULE 13G/A, 2 filings Aug 13, 2025 to Nov 12, 202521
- Bioceres Group LtdSCHEDULE 13D/A, 9 filings Mar 25, 2024 to Oct 28, 202522
- Solel Partners LPSC 13G/A, 2 filings Feb 14, 2023 to Feb 14, 202423
- ARDSLEY ADVISORY PARTNERS LPSC 13G, 1 filing Jan 25, 202324
- Bioceres S.A.SC 13D/A, 4 filings Oct 15, 2021 to Nov 17, 202225
- Ospraie Ag Science LLCSC 13G, 1 filing Jul 15, 202226
- 5DPlus Capital Investment Management Co S.A.SC 13G/A, 2 filings Oct 4, 2021 to Feb 14, 202227
SEC filer profile
How Bioceres Crop Solutions Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBioceres Crop Solutions Corp.1
- CIK0001769484
- Filer statusAccelerated filer not an emerging growth company; not a shell company5
- Incorporated inCayman Islands5
- Fiscal year endsJune 301
- Industry code (SIC)2870 Agricultural Chemicals1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business addressPo Box 309, Ugland House, George Town, Grand Cayman, E9 KY1-11041
- Mailing addressOcampo 210 Bis, Predio Cct, Rosario, C1 20001
- Phone54 341 486 11221
- Shares outstanding63,228,239 shares as of Jun 30, 20255
- AuditorPrice Waterhouse & Co. S.R.L., Rosario, Argentina PCAOB ID 1349; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceMar 14, 20191
- Filings279 in all: 6-K (124), SCHEDULE 13D/A (16), CORRESP (14), UPLOAD (13), SC 13D/A (12), EFFECT (8), SC 13G/A (8), 20-F (7)1
All 40 form types
424B3 (6), SC 13G (6), SCHEDULE 13G (6), 3 (5), 6-K/A (5), F-3 (5), 425 (4), SC TO-I/A (4), SCHEDULE 13G/A (4), S-8 (3), S-8 POS (3), SCHEDULE 13D (3), 4 (2), F-3/A (2), NT 20-F (2), 15-12B (1), 20FR12B (1), 25 (1), 25-NSE (1), 3/A (1), 4/A (1), 424B2 (1), 8-A12B (1), CERT (1), D (1), F-1 (1), F-1/A (1), F-4 (1), F-4/A (1), POS AM (1), SC 13D (1), SC TO-I (1)
- Latest filingsAnnual report (20-F) Nov 10, 2025
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Ordinary Shares, par value US$0.0001 per share | BIOX |
From the cover page of the 20-F filed Nov 10, 2025 (Section 12(b) of the Exchange Act).5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARYogesh Mago, Board member
- 14SEC EDGARNarain Duraiswami, Board member
- 15SEC EDGARJose Augusto Roque, General counsel
- 16NasdaqNasdaq calendar
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27